Reimagining Trust and Credibility in Pharma & Biotech Communications

Session details:

In a time filled with public skepticism, political scrutiny, and rapid scientific progress, it is critical for communications leaders in pharma and biotech to do more than inform—they must build trust, inspire confidence, and navigate uncertainty with clarity and creativity. 

This session brings together communication executives to explore how forward-thinking can elevate corporate communication, cut through noise, and reinforce your organization’s credibility across stakeholders—from investors and regulators to patients and the public. 

Key Takeaways

• Perspectives on what corporate credibility means in 2025/2026 for pharma and biotech organizations.
• Insights on how to build consistent and resilient communications when the environment is rapidly evolving.
• Best practice on identifying and mobilizing authentic story tellers from within our organizations and in partnership with external stakeholders.
• Practical examples from leaders who have maintained corporate credibility through moments of significant challenge.
• Recommendations on key skills and competencies that communications professionals can prioritize to ensure they are able to manage reputation through change in 2026 and beyond.